3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Esophageal Neoplasms
2
Carcinoma, Hepatocellular
2
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Small Cell Lung Carcinoma
1
Recurrence
1
Pancreatic Neoplasms
1
Neoplasms
1
Nasopharyngeal Carcinoma
1
Lung Neoplasms
1
Locally Advanced Rectal Adenocarcinoma
1
Gastric Cancer With Liver Metastases
1
Breast Neoplasms, Male
1
Breast Neoplasms
1
Interventions
Specimen Handling
8
Magnetic Resonance Spectroscopy
7
Biopsy
7
pembrolizumab
6
Doxorubicin
6
Cyclophosphamide
6
X-Rays
4
Radiation
4
Phantoms, Imaging
4
Radiotherapy
3
Nuclear Medicine Department, Hospital
3
Irinotecan
3
Ifosfamide
3
ulixertinib
2
tipifarnib
2
selpercatinib
2
pazopanib
2
palbociclib
2
liposomal doxorubicin
2
ivosidenib
2
fludarabine
2
ensartinib
2
atezolizumab
2
Temozolomide
2
Surveys and Questionnaires
2
Gemcitabine
2
Fluorodeoxyglucose F18
2
Carboplatin
2
Bevacizumab
2
trifluridine tipiracil drug combination
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Sarcoma
×
Immunotherapy
×
30 days
×
Clear all
No trials found.